Critical Metals (CRML) insider plans sale of 50,000 shares

Rhea-AI Filing Summary

Critical Metals Corp. (CRML) submitted a Form 144 notice for a proposed sale of 50,000 common shares, with an aggregate market value of $883,000. The filing shows the shares were acquired as compensation from the issuer on 02/27/2025 and that sale was planned for 10/10/2025 on NASDAQ. The filer reports no securities sold in the prior three months and certifies no undisclosed material adverse information. The filing identifies Oppenheimer & Co. Inc. as the broker.

Positive

• Form 144 filed demonstrating regulatory disclosure for a proposed insider sale
• Broker identified: Oppenheimer & Co. will handle the transaction
• No prior sales in the past three months were reported by the filer

Negative

• Size of sale: 50,000 shares represent approximately 0.048% of outstanding shares (50,000 of 104,912,853), which could exert modest selling pressure
• Acquired recently: shares were received as compensation on 02/27/2025, indicating a short holding period before the planned sale on 10/10/2025

Insights

Securities & Compliance Analyst

TL;DR: A standard Form 144 disclosing an insider sale of 50,000 shares worth $883,000, acquired as compensation on 02/27/2025.

The filing documents a proposed sale under Rule 144 of 50,000 common shares through Oppenheimer & Co. Inc. for an aggregate market value of $883,000 and schedules the approximate sale date as 10/10/2025. The shares were granted as compensation by the issuer on 02/27/2025.

The primary compliance considerations are the filer’s representation of no undisclosed material adverse information and adherence to Rule 144 aggregation/timing requirements. Monitor whether the sale proceeds as scheduled on 10/10/2025 and whether subsequent Form 4 or Form 5 filings appear, which would disclose actual sale details and amounts received.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	Oppenheimer & Co Inc 380 Knollwood Street Winston Salem NC 27103	50000	883000.00	104912853	10/10/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	02/27/2025	compensation	issuer			50000	02/27/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did CRML disclose in the Form 144?

The filer disclosed a proposed sale of 50,000 common shares with aggregate market value $883,000, to be sold on 10/10/2025 via NASDAQ through Oppenheimer & Co. Inc..

When were the shares acquired by the filer?

The shares were acquired as compensation from the issuer on 02/27/2025 and payment was recorded the same day.

Does the filing report any sales in the prior three months?

No. The filing states Nothing to Report for securities sold during the past three months.

What representation did the filer make about material information?

By signing the notice, the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.

Which exchange and broker are involved for the proposed sale?

The sale is designated for NASDAQ and the broker named is Oppenheimer & Co. Inc..